"This body does not want free medicines": South African consumer perceptions of drug quality

Health Policy and Planning

Volumn 25, Issue 1, 2010, Pages 61-69

  Patel, Aarti ^a   Gauld, Robin ^a   Norris, Pauline ^a   Rades, Thomas ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Consumer perceptions; Developing countries; Drug quality; Generic medicines; National medicines policies

Indexed keywords

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CONSUMER SATISFACTION; DEVELOPING COUNTRIES; DRUGS, GENERIC; FEMALE; FOCUS GROUPS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; SOUTH AFRICA; YOUNG ADULT;

EID: 73849106080     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czp039     Document Type: Article

References (35)

1. Bennett S, Quick JD, Velásquez G. 1997. Public-private roles in the pharmaceutical sector: implications for equitable access and rational drug use. Geneva: World Health Organization.
2. Chetley A, Hardon A, Hodgkin C, Haaland A, Fresle A. 2007. How to improve the use of medicines by consumers. Geneva: World Health Organization.
3. Department of Health. 1996. National Drug Policy for South Africa. Pretoria, South Africa: Department of Health.
4. Department of Health. 2001. Access to Quality Affordable Medicine-Your Right! Online at: http://www.doh.gov.za/docs/pr/2001/pr0907.html, accessed 28 July 2008.
5. Dukes MNG, Haaijer-Ruskamp FM, de Joncheere CP, Rietveld AH. 2003. Drugs and Money: Price, affordability and cost containment. Amsterdam: IOS Press.
6. Foster S. 1991. The supply and use of essential drugs in sub-Saharan Africa: some issues and possible solutions. Social Science and Medicine 32: 1201-18.
7. Health Action International and WHO. 2003. Medicine prices-A new approach to measurement-2003 edition. Geneva: Health Action International and World Health Organization.
8. Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Hummers-Pradier E. 2005. What do primary care patients think about generic drugs? International Journal of Clinical Pharmacology and Therapeutics 43: 472-479
9. Hogerzeil HV. 2004. The concept of essential medicines for rich countries. British Medical Journal 329: 1169-1172
10. Hogwood BW, Gunn LA. 1984. Policy analysis for the real world. Oxford: Oxford University Press.
11. Holloway KA, Gautam BR, Harpham T, Takey A. 2002. The influence of user fees and patient demand on prescribers in rural Nepal. Social Science and Medicine 54: 905-918
12. Kitzinger J. 1995. Qualitative Research: Introducing focus groups. British Medical Journal 311: 299-302.
13. Lönnroth K, Tran T, Thuong LM, Quy HT, Diwan V. 2001. Can I afford free treatment? Perceived consequences of health care provider choices among people with tuberculosis in Ho Chi Minh City, Vietnam. Social Science and Medicine 52: 935-948
14. Maïga FI, Haddad S, Fournier P, Gauvin L. 2003. Public and private sector responses to essential drugs policies: a multilevel analysis of drug prescription and selling practices in Mali. Social Science and Medicine 57: 937-948
15. Maponga C, Ondari C. 2003. The quality of antimalarials-a study in selected African countries. Geneva: World Health Organization.
16. McGinnis M. 2008. Matrix of Drug Quality Reports in USAID assisted countries. US Pharmacopeia. Online at: http://www.usp.org/pdf/EN/dqi/ ghcDrugQualityMatrix.pdf, accessed 4 February 2008.
17. McIntyre D, Thiede M. 2007. Health care financing and expenditure. In: Harrison S, Bhana R, Ntuli A (eds). South African Health Review, 2007. Durban: Health Systems Trust.
18. Mrazek MF, Mossialos E. 2000. Increasing demand while decreasing the costs of generic medicines. The Lancet 356: 1784-1785
19. Newton PN, Green MD, Fernandez FM, Day NPJ, White NJ. 2006. Counterfeit anti-infective drugs. The Lancet Infectious Diseases 6: 602-613
20. Patton MQ. 2002. Qualitative Research & Evaluation Methods. Newbury Park, CA: Sage Publications.
21. Perry G. 2003. Editorial. Journal of Generic Medicines 1: 4-5.
22. Quick JD, Rankin JR, Laing RO et al. (eds). 1997. Managing Drug Supply: The selection, procurement, distribution and use of pharmaceuticals. 2nd edn. West Hartford, CT: Kumarian Press.
23. Ratanawijitrasin S, Wondemagegnehu E. 2002. Effective drug regulation: A multicountry study. Geneva: World Health Organization.
24. Rondganger L. 2007. Crime, Security in South Africa. Independent Online (IOL). Online at: http://www.iol.co.za/index.php?set-id=1&click-id= 3045&art-id=vn20071106033542483C943656, accessed 26 April 2009.
25. Shakoor O, Taylor RB, Behrens RH. 1997. Assessment of the incidence of substandard drugs in developing countries. Tropical Medicine and International Health 2: 839-845
26. Strauss A, Corbin J. 1990. Basics of qualitative research-grounded theory procedures and techniques. Newbury Park, CA: Sage Publications.
27. Syhakhang L, Lundborg CS, Lindgreen B, Tomson G. 2004a. The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999. Pharmacy World and Science 26: 333-338
28. Syhakhang L, Freudenthal S, Tomson G, Wahlström R. 2004b. Knowledge and perceptions of drug quality among drug sellers and consumers in Lao PDR. Health Policy and Planning 19: 391-401.
29. Tootelian DH, Gaedeke RM, Schlacter J. 1988. Branded versus generic prescription drugs: perceptions of risk, efficacy, safety and value. Journal of Health Care Marketing 8: 26-29.
30. Treatment Action Campaign. 1998. Day of Action. Online at: http://www.tac.org.za/treat.html, accessed 1 July 2008.
31. van der Geest S, Whyte SR. 1988. The context of medicines in developing countries: Studies in pharmaceutical anthropology. Dordrecht, Netherlands: Kluwer Academic Publishers.
32. WHO. 2001. How to develop and implement a national drug policy. Geneva: World Health Organization.
33. WHO. 2004. WHO Medicines Strategy: Countries at the core, 2004-2007. Geneva: World Health Organization.
34. Whyte SR, van der Geest S, Hardon A. 2002. Social Lives of Medicines. Cambridge: Cambridge University Press.
35. Yelkur R, Capella LM. 1995. Generic Prescription Drugs: Awareness, attitudes and intentions of Elderly consumers. Online at: http://www.sbaer.uca. edu/research/sma/1995/pdf/12.pdf, accessed 8 May 2008.